*Frontiers in Pharmacology*, 12, 634151
The molecule was developed by the Australian pharmaceutical company Metabolic Pharmaceuticals (in collaboration with Monash University) and advanced through Phase I safety trials and a Phase IIb obesity efficacy trial enrolling approximately 900 participants in total
Full catalog MOTS-c Side Effects: Trials and User Reports adverse event profile from clinical trials and community reports MOTS-c Dosing Guide protocols, cycles, and administration MOTS-C Bloodwork Guide what labs to track and optimal ranges BPC-157 Reconstitution Guide the standard reconstitution reference Semaglutide Reconstitution Guide mixing guide for GLP-1 agonist Retatrutide Reconstitution Guide mixing guide for the triple-receptor agonist SS-31 Dosing Guide another mitochondrial peptide often paired with MOTS-C Calculate Your MOTS-c Cycle Cost estimate vials needed and total cost for your protocol References Lee, C., et al
Our providers build a personalized, provider-led plan around your labs, goals, and health history, then guide you through it safely
Hany Demian, MD, a board-certified physician in pain management and aesthetic medicine and the CEO and founder of Praesentia Health and BioSpine Institute in Fort Myers, Florida